Literature DB >> 1732114

Cellular localization of procollagen gene transcripts in inflammatory bowel diseases.

H Matthes1, H Herbst, D Schuppan, A Stallmach, S Milani, H Stein, E O Riecken.   

Abstract

The cellular localization of procollagen types I, III, IV, and V gene transcripts was determined in tissues from 12 patients with either Crohn's disease (CD) or ulcerative colitis (UC) and nine controls by in situ hybridization with 35S-labeled RNA probes. In CD, the signal intensity and number of labeled cells were significantly increased, particularly in deeper intestinal layers. In contrast, the labeled cells in UC were concentrated in the subepithelial intestinal layers, with an overexpression of procollagen III RNA transcripts. Immunohistological stainings for procollagen types I, III, and IV showed a weaker staining in UC than in CD, indicating that increased transcript levels in UC are unrelated to the enhanced collagen protein deposition, although the increase of procollagen messenger RNA levels correlated with the density of the inflammatory infiltrate. It was concluded that both CD and UC show highly increased procollagen RNA transcript levels but differ in collagen deposition. Thus, different posttranscriptional or posttranslational regulatory mechanisms, such as collagen degradation, may account for the observed differences.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732114     DOI: 10.1016/0016-5085(92)90087-f

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

1.  Stricture formation in Crohn's disease: the role of intestinal fibroblasts.

Authors:  M C Regan; B M Flavin; J M Fitzpatrick; P R O'Connell
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis.

Authors:  A Stallmach; C C Chan; K W Ecker; G Feifel; H Herbst; D Schuppan; M Zeitz
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

Review 3.  Fistulising Crohn's disease: MMPs gone awry.

Authors:  D Schuppan; T Freitag
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 4.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 5.  Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin?

Authors:  Mariabeatrice Principi; Floriana Giorgio; Giuseppe Losurdo; Viviana Neve; Antonella Contaldo; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15

6.  Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease.

Authors:  S Daum; U Bauer; H D Foss; D Schuppan; H Stein; E O Riecken; R Ullrich
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

7.  Gastric ulcer healing in the rat: kinetics and localisation of de novo procollagen synthesis.

Authors:  M Shahin; A Gillessen; T Pohle; C Weber; D Schuppan; H Herbst; W Domschke
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

8.  Characterizing intestinal strictures of Crohn's disease in vivo by endoscopic photoacoustic imaging.

Authors:  Hao Lei; Laura A Johnson; Kathryn A Eaton; Shengchun Liu; Jun Ni; Xueding Wang; Peter D R Higgins; Guan Xu
Journal:  Biomed Opt Express       Date:  2019-04-24       Impact factor: 3.732

9.  Evidence of delayed gastrointestinal syndrome in high-dose irradiated mice.

Authors:  Catherine Booth; Gregory Tudor; Nicola Tonge; Terez Shea-Donohue; Thomas J MacVittie
Journal:  Health Phys       Date:  2012-10       Impact factor: 1.316

10.  Halofuginone, a specific inhibitor of collagen type 1 synthesis, ameliorates oxidant colonic damage in rats with experimental colitis.

Authors:  Berna Karakoyun; Meral Yüksel; Feriha Ercan; Emine Salva; Işil Işik; Berrak C Yeğen
Journal:  Dig Dis Sci       Date:  2009-04-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.